Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
Pacira BioSciences (NASDAQ: PCRX), a leader in non-opioid pain therapies, has announced its participation in two upcoming healthcare conferences. The company will engage in analyst-led fireside chats at:
- The 2025 RBC Capital Markets Global Healthcare Conference on May 21st at 8:30 AM ET
- The 2025 Jefferies Global Healthcare Conference on June 4th at 8:45 AM ET
Both events will be accessible via live audio webcast through the "Events" page on Pacira's investor website. Recordings will remain available for two weeks after each event.
Pacira BioSciences (NASDAQ: PCRX), leader nelle terapie per il dolore non oppioidi, ha annunciato la sua partecipazione a due prossimi convegni nel settore sanitario. L'azienda parteciper脿 a colloqui informali guidati da analisti durante:
- La 2025 RBC Capital Markets Global Healthcare Conference il 21 maggio alle 8:30 ET
- La 2025 Jefferies Global Healthcare Conference il 4 giugno alle 8:45 ET
Entrambi gli eventi saranno accessibili in diretta audio streaming tramite la pagina "Events" sul sito dedicato agli investitori di Pacira. Le registrazioni saranno disponibili per due settimane dopo ogni evento.
Pacira BioSciences (NASDAQ: PCRX), l铆der en terapias para el dolor no opioides, ha anunciado su participaci贸n en dos pr贸ximas conferencias de salud. La compa帽铆a participar谩 en charlas informales dirigidas por analistas en:
- La 2025 RBC Capital Markets Global Healthcare Conference el 21 de mayo a las 8:30 AM ET
- La 2025 Jefferies Global Healthcare Conference el 4 de junio a las 8:45 AM ET
Ambos eventos estar谩n disponibles a trav茅s de una transmisi贸n de audio en vivo en la p谩gina "Events" del sitio web para inversores de Pacira. Las grabaciones estar谩n accesibles durante dos semanas despu茅s de cada evento.
Pacira BioSciences (NASDAQ: PCRX)電� 牍勲鞎届劚 歆勴喌鞝� 攵勳暭鞚� 靹犽憪欤检瀽搿滌劀, 雼り皜鞓る姅 霊� 臧滌潣 項姢旒�鞏� 旎嵓霟办姢鞐� 彀胳棳頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 雼れ潓 頄夓偓鞐愳劀 鞎犽剱毽姢韸� 欤茧弰鞚� 雽�頇旍棎 彀胳棳頃� 瓴冹瀰雼堧嫟:
- 2025 RBC Capital Markets Global Healthcare Conference, 5鞗� 21鞚� 鞓れ爠 8鞁� 30攵� ET
- 2025 Jefferies Global Healthcare Conference, 6鞗� 4鞚� 鞓れ爠 8鞁� 45攵� ET
霊� 頄夓偓 氇憪 Pacira 韴瀽鞛� 鞗轨偓鞚错姼鞚� "Events" 韼橃澊歆�毳� 韱淀暣 霛检澊敫� 鞓る敂鞓� 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨溂氅�, 臧� 頄夓偓 頉� 2欤缄皠 雲鬼檾霅� 鞓侅儊霃� 鞝滉车霅╇媹雼�.
Pacira BioSciences (NASDAQ : PCRX), leader dans les th茅rapies non opio茂des contre la douleur, a annonc茅 sa participation 脿 deux prochaines conf茅rences dans le secteur de la sant茅. La soci茅t茅 participera 脿 des discussions informelles anim茅es par des analystes lors de :
- La 2025 RBC Capital Markets Global Healthcare Conference le 21 mai 脿 8h30 ET
- La 2025 Jefferies Global Healthcare Conference le 4 juin 脿 8h45 ET
Les deux 茅v茅nements seront accessibles en direct via un webcast audio sur la page 芦 Events 禄 du site investisseurs de Pacira. Les enregistrements resteront disponibles pendant deux semaines apr猫s chaque 茅v茅nement.
Pacira BioSciences (NASDAQ: PCRX), ein f眉hrendes Unternehmen im Bereich nicht-opioider Schmerztherapien, hat seine Teilnahme an zwei bevorstehenden Gesundheitskonferenzen angek眉ndigt. Das Unternehmen wird an von Analysten gef眉hrten Gespr盲chen teilnehmen bei:
- Der 2025 RBC Capital Markets Global Healthcare Conference am 21. Mai um 8:30 Uhr ET
- Der 2025 Jefferies Global Healthcare Conference am 4. Juni um 8:45 Uhr ET
Beide Veranstaltungen werden per Live-Audio-Webcast 眉ber die 鈥濫vents鈥�-Seite auf der Investorenseite von Pacira zug盲nglich sein. Aufzeichnungen sind zwei Wochen nach jeder Veranstaltung verf眉gbar.
- None.
- None.
BRISBANE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences:
- 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21st at 8:30AM ET.
- 2025 Jefferies Global Healthcare Conference on Wednesday, June 4th at 8:45AM ET.
Live audio of the virtual event can be accessed by visiting the 鈥淓vents鈥� page of the company鈥檚 website at . A replay of the webcast will also be available for two weeks following the event.
About Pacira
Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL庐 (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA庐 (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera潞庐, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing the development of PCRX-201 (enekinragene inzadenovec), a novel locally administered gene therapy with the potential to treat large prevalent diseases like osteoarthritis. To learn more about Pacira, visit .
Company Contact: Pacira BioSciences, Inc. Christian Pedetti (973) 254-4387 [email protected]
FAQ
When is Pacira BioSciences (PCRX) presenting at the RBC Capital Markets Healthcare Conference 2025?
How can I access Pacira BioSciences' (PCRX) presentations at the 2025 healthcare conferences?
What healthcare conferences is Pacira BioSciences (PCRX) attending in 2025?
When will Pacira BioSciences (PCRX) present at the Jefferies Global Healthcare Conference 2025?
